1. < Pancreatic Disorders
Profile picture for howleegirl

ALTA3263 Trial

Posted by howleegirl @howleegirl, May 30 6:55am

Docs have put Bob in this trial until Daraxonrasib is available to him. Anyone on here familiar with this trial?

Interested in more discussions like this? Go to the Pancreatic Disorders Support Group.

Profile picture for mcharlesfrancis
mcharlesfrancis | @mcharlesfrancis | May 30 8:31am

Unlike some older KRAS drugs that target only one mutation (such as G12C), ALTA3263 was designed to inhibit multiple KRAS mutations and may potentially cover more than 90% of KRAS variants.
* It is currently being tested alone and in combination with cetuximab.

REPLY
Please sign in or register to post a reply.